Last update 06 Nov 2024
Ranitidine Hydrochloride/Bismuth Potassium Citrate/Sucralfate
Last update 06 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms DWP-302 |
Target |
Mechanism H2 receptor antagonists(Histamine H2 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (01 Nov 2012), |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC12H54Al16O75S8 |
InChIKeyDTULOKYBGCTCFP-QRLOXDDHSA-A |
CAS Registry54182-58-0 |
View All Structures (3)
Related
1
Clinical Trials associated with Ranitidine Hydrochloride/Bismuth Potassium Citrate/SucralfateProtective Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
100 Clinical Results associated with Ranitidine Hydrochloride/Bismuth Potassium Citrate/Sucralfate
Login to view more data
100 Translational Medicine associated with Ranitidine Hydrochloride/Bismuth Potassium Citrate/Sucralfate
Login to view more data
100 Patents (Medical) associated with Ranitidine Hydrochloride/Bismuth Potassium Citrate/Sucralfate
Login to view more data
100 Deals associated with Ranitidine Hydrochloride/Bismuth Potassium Citrate/Sucralfate
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Stomach Ulcer | KR | 01 Nov 2012 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free